Africa Molecular Diagnostics Market Size & share Analysis - Growth, Trends, & Forecasts (2024-2029)

Africa Molecular Diagnostics Market Analysis

The Africa Molecular Diagnostics Market size is estimated at USD 349.28 million in 2024, and is expected to reach USD 504.68 million by 2029, growing at a CAGR of 7.64% during the forecast period (2024-2029).

Some of the key factors driving the growth of the molecular diagnostics market in Africa include the growing demand for point-of-care diagnostics in the region, the growing burden of bacterial and viral diseases, and countries receiving funding from international organizations in the molecular diagnostics space.

The high disease burden in Africa creates a strong need for accurate and rapid diagnostics. For instance, an article published by Dove Press in July 2022 stated that, in sub-Saharan Africa (SSA), prevalence rates ranging from 14.7% to 82% were reported in countries like Nigeria, Gabon, Burkina Faso, Kenya, South Africa, and Tanzania. Children under the age of five have the highest risk of bacterial as well as viral infection in the region. Transmission is via the fecal route, either directly through person-to-person contact or indirectly through contaminated food and water. To cope with the rising burden of bacterial diseases, the region's diagnostic industry is taking steps that are expected to boost the demand for the molecular diagnostics market in Africa.

Furthermore, African countries are getting assistance from various organizations and associations, which is a beneficial factor in market growth. For instance, in July 2022, the World Bank approved a USD 100 million support program for the Africa Centre for Disease Control (Africa CDC) to enhance the institution’s technical capacity and strengthen its institutional framework to intensify support to African countries to prepare for detecting and responding to disease outbreaks and public health emergencies. With such funding from international organizations, the market for molecular diagnostics is expected to grow strongly during the forecast period.

Many African regions lack well-equipped healthcare facilities and trained personnel. There is a large gap between diagnostic needs and diagnostic access across much of sub-Saharan Africa (SSA), particularly for infectious diseases that inflict a substantial burden of morbidity. For instance, in an article published by PLOS Digital Health in June 2022, at least 50% of the population does not have access to essential health services. Advances in molecular diagnostics can accelerate healthcare provision toward Universal Health Coverage (UHC), bringing high-quality diagnostics and decision-support tools to the point of care. Hence, in the African region, many people lacking essential health services will further raise the need for molecular diagnostic services with the help of government initiatives anticipated to fuel the market's growth in the forecast period.

However, the high cost of disease diagnostics and the lack of trained healthcare professionals are expected to hamper the market growth in the coming years.

Africa Molecular Diagnostics Market Trends

Oncology Segment is Expected to Witness a Strong Growth During the Forecast Period

Africa Molecular Diagnostics Industry Segmentation

As per the scope of the report, molecular diagnostic tests detect specific sequences in DNA or RNA (including single nucleotide polymorphisms (SNP), deletions, rearrangements, insertions, and others), which may or may not be associated with diseases. Molecular diagnostics has been revolutionized over the past few decades. Africa Molecular Diagnostics Market is segmented by technology, application, product, end user, and geography. The market is segmented by technology into in situ hybridization, chips and microarrays, mass spectrometry (MS), sequencing, PCR, and other technologies. The market is segmented by application into infectious disease, oncology, pharmacogenomics, microbiology, genetic disease screening, human leukocyte antigen typing, and blood screening. By product, the market is segmented into instruments, reagents, and other products. By end user, the market is segmented into hospitals, laboratories, and other end users. The report also covers the estimated market sizes and trends for 17 countries across major regions globally. The report offers the value (in USD) for the above segments.